Literature DB >> 9141497

Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation.

H Glatt1.   

Abstract

Sulfation is a common final step in the biotransformation of xenobiotics and is traditionally associated with inactivation. However, the sulfate group is electron-withdrawing and may be cleaved off heterolytically in some molecules, leading to an electrophilic cation. The stable heterologous expression of sulfotransferases in indicator cells of standard mutagenicity tests has substantially improved the accessibility of this activation pathway. Sulfotransferase-mediated genotoxic effects have been demonstrated for numerous benzylic alcohols derived from polycyclic aromatic hydrocarbons and various aromatic hydroxylamines. Also, hycanthone (a benzylic alcohol), alpha-hydroxytamoxifen (an allylic alcohol), 1'-hydroxysafrole (an allylic/benzylic alcohol), and 2-nitropropane are activated to genotoxicants by sulfotransferases. Various reactive sulfate conjugates show strong mutagenic effects only when they are generated directly within the indicator cell, due to their inefficient penetration of cell membranes. In other cases, secondary membrane-penetrating reactive species are formed from sulfuric acid esters by displacement reactions with medium components, such as chloride or amino acids. Reaction with water regenerates the alcohol, which becomes available for a new cycle of activation. Different sulfotransferases from the same species as well as related forms from rat and human differ in their substrate specificities and tissue distributions. These characteristics and reactivities of the sulfate conjugates formed may explain organotropic effects of the compounds activated via sulfotransferases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141497     DOI: 10.1096/fasebj.11.5.9141497

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  32 in total

1.  Mechanistic studies of beta-arylsulfotransferase IV.

Authors:  Eli Chapman; Marian C Bryan; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

Review 2.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 3.  Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.

Authors:  Susumu Kodama; Masahiko Negishi
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

4.  Identification of sulfation sites of metabolites and prediction of the compounds' biological effects.

Authors:  Lin Yi; Joe Dratter; Chao Wang; Jon A Tunge; Heather Desaire
Journal:  Anal Bioanal Chem       Date:  2006-05-25       Impact factor: 4.142

5.  Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population.

Authors:  Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki
Journal:  Int Urol Nephrol       Date:  2008-03-27       Impact factor: 2.370

6.  Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.

Authors:  Shih-Yu Chang; Elijah J Weber; Viktoriya S Sidorenko; Alenka Chapron; Catherine K Yeung; Chunying Gao; Qingcheng Mao; Danny Shen; Joanne Wang; Thomas A Rosenquist; Kathleen G Dickman; Thomas Neumann; Arthur P Grollman; Edward J Kelly; Jonathan Himmelfarb; David L Eaton
Journal:  JCI Insight       Date:  2017-11-16

7.  A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer.

Authors:  Stefania Boccia; Gabriella Cadoni; Giuseppe La Torre; Dario Arzani; Mariangela Volante; Caterina Cattel; Francesco Gianfagna; Gaetano Paludetti; Giovanni Almadori; Gualtiero Ricciardi
Journal:  J Cancer Res Clin Oncol       Date:  2006-03-31       Impact factor: 4.553

8.  The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase.

Authors:  Annette Cronin; Sherry Mowbray; Heike Dürk; Shirli Homburg; Ingrid Fleming; Beate Fisslthaler; Franz Oesch; Michael Arand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

9.  Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.

Authors:  Paras B Singh; Narasimhan Ragavan; Katherine M Ashton; Prabir Basu; Sayeed M Nadeem; Caroline M Nicholson; R K Gopala Krishna; Shyam S Matanhelia; Francis L Martin
Journal:  Asian J Androl       Date:  2009-11-23       Impact factor: 3.285

10.  Fungal biotransformation of 6-nitrochrysene.

Authors:  J V Pothuluri; J B Sutherland; J P Freeman; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1998-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.